Atherothrombotic events and clopidogrel therapy
- PMID: 17261834
- PMCID: PMC1780104
- DOI: 10.1503/cmaj.1060153
Atherothrombotic events and clopidogrel therapy
Comment on
-
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.CMAJ. 2006 Jun 6;174(12):1715-22. doi: 10.1503/cmaj.060664. CMAJ. 2006. PMID: 16754899 Free PMC article. Clinical Trial.
References
-
- Biondi-Zoccai GG, Agostoni P, Sangiorgi GM, et al; TRUE (Taxus in Real-Life Usage Evaluation) Study Investigators. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) study. Int J Cardiol 2006;108:406-7. - PubMed
-
- Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes 2006;55:780-4. - PubMed
-
- Jimenez-Quevedo P, Angiolillo DJ, Bernardo E, et al. Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: Need to assess aspirin resistance? Catheter Cardiovasc Interv 2004;62:39-42. - PubMed
-
- Almsherqi ZA, McLachlan CS, Sharef SM. More on: enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized cross-over trial [letter]. J Thromb Haemost 2006;4:1-2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical